Navigation Links
New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population
Date:9/1/2011

WASHINGTON, Sept. 1, 2011 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive.  The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival.  

Xalkori targets the echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) mutation. According to the FDA, the mutation is only present in 1-7% of people with NSCLC, primarily those diagnosed with adenocarcinoma.

"This is exciting news," said LCA President & CEO, Laurie Fenton Ambrose.  "Personalized medicine is where we are headed for lung cancer treatments.  This is one of the first steps towards identifying medications that help select populations of people.  We must continue to identify other mutations and find drugs that treat them to finally see cures for lung cancer." 

"I was enrolled in the phase I trial for this drug," said Linnea Duff, NH resident and longtime lung cancer survivor.  "At the time I began the trial, I was hoping to have my life extended for a few months. Instead, I got three more years to spend with my family and friends. In addition, because this was a targeted therapy, the side effects were minimal and my quality of life during this time has been remarkable."

Xalkori has shown a life changing response to lung cancer in those patients who are ALK positive.  Lung Cancer Alliance encourages lung cancer patients to discuss genetic testing options with their health care team.  

It is important to note that many genetic mutations have been identified but not all have drugs to target the mutations at this time. With continued focus from researchers and increased participation in clinical trials, more and more of these personalized therapies will become available.  


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Unapproved Emergency Birth Control Medicine Possibly in U.S. Distribution May Be Ineffective and Unsafe
2. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
3. Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
4. Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
5. TandemHeart Approved for Expanded Reimbursement
6. Breast Cancer Patients and Families Decry FDA Panel Vote to Remove Life Saving Drug From Approved List
7. Laureates Electronic Submission Gateway Approved
8. Capacity Constraints Continue to Loosen for Suzhou Erye Pharmaceuticals as a New Production Line is Approved by the China SFDA
9. Approved Biologic Therapies in Rheumatoid Arthritis Show Further Evidence of Efficacy and Reduction in Joint Damage at the 2011 European League Against Rheumatisms Congress
10. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
11. FDA Expands Approved Use For Carotid Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 The preclinical contract research organization Absorption ... and safety testing of medical devices, announces that its Chief ... workshop " Drug Transporters in ADME: From the Bench to ... The title of Dr. Hidalgo,s talk is "Modern Tools for ... "Transporter Tools of the Future." The workshop, organized ...
(Date:4/20/2015)... Ingenuity Health, a leading provider of monitoring solutions to ... National Council of Behavioral Health annual conference in ... percent of the samples collected from patients with serious ... medication. ... Medication nonadherence can result ...
(Date:4/20/2015)... LINCOLNSHIRE, Ill. , April 20, 2015  U.S. pharmacy ... are expected to drift into the low double-digits by 2016, ... global talent, retirement and health solutions business of Aon ... plan design changes are projected to be 9.5 percent in ... 2016. Aon Hewitt predicts a similar rate of ...
Breaking Medicine Technology:Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
... 26, 2011 Hamilton Company has been awarded a ... announced today. Hamilton Company, the Reno, NV-based global leader in ... investment in the manufacturing facility of its Swiss subsidiary Hamilton ... Named after Swiss national hero Wilhelm Tell, the Awards are ...
... 2011 Pinktimeline.com launched as a resource for the ... of First Response, and Zita West, fertility expert and midwife to ... for a baby. First Response has announced the launch of a ... trying for a baby, especially during the ,2-week wait., ...
Cached Medicine Technology:Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 2Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 3First Response Partners With Fertility Expert Zita West to Support Those Trying for a Baby 2
(Date:4/20/2015)... NY (PRWEB) April 21, 2015 ... a 2015 Professional Woman of the Year. Ms. Webb ... healthcare. As the largest, most-recognized networking organization of professional ... profession, the National Association of Professional Women is a ... over 200 local chapters. , “We are like an ...
(Date:4/20/2015)... The NFL draft season is here and teams ... to their rosters, both for their skills on the field ... SCI TV , Vinnie Iyer of Sporting News ... given increased attention on off-field conduct in the NFL. The ... Rice scandal brought media scrutiny, once again, to behavior off ...
(Date:4/20/2015)... At the famous Avalon Hollywood on April ... EcoLuxe Lounge, with Choices Recovery as the premier sponsor. ... product placement in TV and film, gathered some of ... sound goods and services for this daylong event. ... Choices Celebrity Interview Lounge, speaking with many of the ...
(Date:4/20/2015)... Goodreads is sponsoring a book giveaway ... Good for You and Your Company between Mar. 31 ... Rick Lindquist have released a new book entitled, ... for You and Your Company. The book discusses the ... - employer-funded individual health insurance. , According to ...
(Date:4/20/2015)... Early registration is open for the 2nd Annual ... the start line. Returning to James Kealoha Beach Park ... 500 participants (actually there’s only 499 spots since Big Island ... thru April 30, the entry fee is only $150 for ... the fee goes up to $200 and $100, respectively. Registration ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Suzanne Webb, Chief Executive Officer at Exclusive Surgeries Network, LLC, a 2015 Professional Woman of the Year 2Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3
... Institute for Biological Studies announced that Dr. Axel Nimmerjahn, Assistant ... the Richard Allan Barry Developmental Chair, has been named a ... out of 28 candidates to be selected this year and ... "To be chosen for the Rita Allen Foundation Scholars ...
... , TUESDAY, June 21 (HealthDay News) -- The frequency of ... of diabetes in the United States over the past two ... people with diabetes develop diabetic kidney disease (DKD), which is ... nearly half of all new cases of kidney failure in ...
... who are diagnosed with prostate cancer and who are ... cardiovascular and prostate cancer-specific death, according to a study ... These patients also had an increased likelihood of prostate ... increase risk of aggressive prostate cancer and prostate cancer ...
... world will gather in Cincinnati next month to ... a dreaded, life-threatening complication of subarachnoid hemorrhage, while ... generate the first set of guidelines in neurocritical ... suffered a subarachnoid hemorrhage, or bleeding stroke. ...
... News) -- Only 11 percent of patients who experience a ... be transferred to another hospital for procedures such as balloon ... of 30 minutes. Instead, a new study finds the ... hour, a delay that researchers say may increase the risk ...
... (HealthDay News) -- Smokers diagnosed with prostate cancer are more ... more likely to die than non-smokers, a new study says. ... Follow-Up Study who were diagnosed with prostate cancer between 1986 ... men, including 524 (32 percent) from prostate cancer and 416 ...
Cached Medicine News:Health News: Salk scientist named Rita Allen Scholar 2Health News:Diabetic Kidney Disease Rising in the U.S. 2Health News:Being a smoker at time of prostate cancer diagnosis linked with increased risk of death 2Health News:International Vasospasm 2011 conference could be springboard for treatment guidelines 2Health News:International Vasospasm 2011 conference could be springboard for treatment guidelines 3Health News:Delays in Hospital Transfers for Heart Attack Patients May Raise Death Risk 2Health News:Smoking, Prostate Cancer a Deadly Mix 2
Steerable catheter that is ideal for mapping unusual anatomy...
... The LASSO Circular Mapping Catheter from Biosense ... of circumferentially mapping the myocardial sleeves around ... allows the sequential assessment of PV potentials ... isolation. The circular LASSO curve with ...
Standard Deflectable Catheters...
... The reliable, easy-to-steer Bart EPXT ... shaft stability and curve control for ... point-of-tip actuation control supplies exceptional levels ... extraordinary family of small, medium and ...
Medicine Products: